+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025

  • ID: 5018600
  • Report
  • April 2020
  • Region: Global
  • 268 Pages
  • Markets and Markets
The CRO Services Market is Expected to Reach USD 73.77 Billion by 2025 from USD 47.77 Billion in 2020, at a CAGR of 9.1% from 2020 to 2025.


  • Acculab Lifesciences
  • ICON Plc
  • Medpace Holdings
  • PPD
  • SGS

Increased outsourcing of R&D activities and an increasing number of clinical trials are some of the major factors driving the growth of this market. However, lack of skilled labor in the CRO services market is one of the major challenges for the players operating in CROs market.

Data management services segment to witness the highest growth rate during the forecast period.

Among the CRO services, the laboratory services segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing outsourcing of data management services by pharmaceutical and biopharmaceutical companies.

Oncology segment to grow at the highest CAGR from 2020 to 2025.

The oncology segment is expected to grow at the highest CAGR during the forecast period. The increasing number of clinical trials and the rising prevalence of cancer worldwide are the major factors supporting its growth during the forecast period.

APAC to witness the highest growth rate during the forecast period.

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapid growth in the pharmaceutical and biopharmaceutical industry, low cost of clinical trials, rising number of CROs, and favorable government policies in the region.

Break of primary participants:

  • By Company Type - Tier 1: 42%, Tier 2-13%, and Tier 3-45%
  • By Designation - C Level: 17%, Director Level: 25%, and Others: 58%
  • By Region - North America: 20%, Europe: 28%, Asia Pacific: 18%, Latin America: 25%, and the Middle East & Africa: 9%

Research Coverage:

The report analyzes the various CRO services and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global CRO services market for different segments such as type, therapeutic area, end-user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the CRO services market
  • Service Launch/Innovation: Detailed insights on new service launches in the CRO services market
  • Market Development: Comprehensive information about lucrative emerging markets, by type, therapeutic area, end-user, and region
  • Market Diversification: Exhaustive information about new services, growing geographies, recent developments in the CRO services market
  • Competitive Assessment: In-depth assessment of growth strategies, services, and manufacturing capabilities of leading players in the CRO services market
Note: Product cover images may vary from those shown


  • Acculab Lifesciences
  • ICON Plc
  • Medpace Holdings
  • PPD
  • SGS

1 Introduction
1.1 Objectives of the study
1.2 Market definition
1.3 Market scope
1.3.1 Markets covered
1.3.2 Years considered for the study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research approach
2.2 Market size estimation
2.3 Market breakdown and data triangulation
2.4 Market share estimation
2.4.1 Key data from secondary sources
2.5 Key data from primary sources
2.5.1 Key Industry Insights
2.6 Assumptions for the study

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market segmentation
5.3 Market Dynamics
5.3.1 Drivers Growing R&D expenditures Increased outsourcing of R&D activities Increasing demand for outsourcing analytical testing and clinical trial services Increase in clinical trials
5.3.2 Restraints Regulatory pressure on CROs
5.3.3 Opportunities Growing biosimilars and biologics market Rising demand for specialized testing services
5.3.4 Challenges Growing competition in the CRO industry Regulatory pressure on pharma and medical device manufacturers to drive more detailed chemical analysis of drugs, and devices Shortage of skilled professionals

6 Industry Insight
6.1 Industry Trends
6.1.1 Growing consolidation in the CROs industry
6.1.2 Globalization of clinical trials
6.1.3 Increasing demand for outsourcing various services and preferred vendor partnerships
6.1.4 Technological Advancement

7 Contract Research Organization Market, By Services
7.1 Introduction
7.2 Early Phase Development Services
7.2.1 Discovery Studies
7.2.2 Chemistry, Manufacturing & Control
7.2.3 Preclinical Pharmacokinetics/Pharmacodynamics (PK/PD) Toxicology Testing Other Preclinical Services
7.3 Clinical Research Services
7.3.1 Phase I
7.3.2 Phase II
7.3.3 Phase III
7.3.4 Phase IV
7.4 Laboratory Services
7.4.1 Bioanalytical Testing
7.4.2 Analytical Testing Physical Characterization Stability Testing Batch Release Testing Raw Material Testing Other Analytical Testing
7.5 Consulting Services
7.6 Data Management Services

8 Contract Research Organization Market, By Therapeutic Areas
8.1 Oncology
8.2 Central Nervous System
8.3 Cardiovascular
8.4 Respiratory
8.5 Infectious Diseases
8.6 Autoimmune Disorders
8.7 Diabetes
8.8 Others

9 Contract Research Organization Market, By End User
9.1 Pharmaceutical and Biopharmaceutical Companies
9.2 Medical Device Companies
9.3 Academic Institutes

10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 APAC
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 RoAPAC
10.4.5 Latin America
10.4.6 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation & Trends
11.3.1 Agreements, collaborations, joint ventures, and partnerships
11.3.2 Expansions
11.3.3 Mergers and acquisitions
11.3.4 New Service launches

12 Company Profiles
12.1 IQVIA
12.2 LabCorp
12.3 Charles River Laboratories
12.4 WuXi Apptec
12.5 Syneos Health Inc.
12.6 Paraxel International
12.7 PRA Health Sciences
12.8 PPD
12.9 ICON Plc
12.10 Medpace Holdings
12.11 SGS
12.12 PSI CRO AG
12.13 Axcent Advanced Analytics (A3)
12.14 BIO Agile Therapeutics
12.15 Firma Clinical Research
12.16 Acculab Lifesciences
12.17 Azelix
12.18 CTSERV
12.19 PEPGRA
12.20 Dove Quality Solutions

13 Appendix
13.1 Insights of industry experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Subscription Portal
13.5 Available customizations
13.6 Introducing RT: Real-Time Market Intelligence

Note: Product cover images may vary from those shown


  • Acculab Lifesciences
  • Axcent Advanced Analytics (A3)
  • Azelix
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Dove Quality Solutions
  • Firma Clinical Research
  • ICON Plc
  • LabCorp
  • Medpace Holdings
  • Paraxel International
  • PPD
  • PRA Health Sciences
  • SGS
  • Syneos Health Inc.
  • WuXi Apptec
Note: Product cover images may vary from those shown